+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia-Pacific Fluoroscopy Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5119832
  • Report
  • June 2020
  • Region: Asia Pacific
  • 90 Pages
  • Mordor Intelligence

FEATURED COMPANIES

  • Carestream Health
  • Hitachi Medical Systems
  • Hologic Inc.
  • Koninklijke Philips NV
  • Orthoscan Inc.
  • Shimadzu Medical
Fluoroscopy devices market is primarily driven by rising demand for minimally-invasive surgeries, growing geriatric population, the prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.

Medical imaging has applications at various stages of inpatient management processes, such as diagnosis, staging, therapy delivery, and its follow-ups. The primary role for imaging has been diagnostics, but it is increasing slowly for interventional diagnostics and therapeutic uses that are driven by minimally-invasive procedures. Fluoroscopy presents real-time moving images for the diagnostic evaluation of soft and hard tissue conditions. It is an indispensable tool for many interventional medical procedures. The fluoroscopy market is anticipated to register significant growth, with an increasing number of minimally-invasive surgeries that are of high-precision, including the devices used, resulting in better support for both patients and surgeons. In December 2017, Hologic Inc. introduced Fluoroscan InSight FD Mini C-Arm extremities imaging system at the 2017 Radiological Society of Asia-Pacific (RSNA) annual conference in Chicago. The advancemnets in the products and new roduct launches in teh region is also boosting the market. However, the side effects associated with radiation is expected to hinder the market growth over the forecast period.

Key Market Trends

The Cardiovascular Segment, under Application, is Expected to Account for the Largest Market Share, during the Forecast Period

Cardiovascular procedures require extensive fluoroscopic guidance to navigate endovascular catheters. The fluoroscopy provides excellent spatial and temporal resolution, having a limitation of exposure of ionizing radiation to the patients and staff, along with poor soft tissue characterization. In the process of cardiac catheterization, fluoroscopy is used to help the healthcare provider see the flow of blood through the coronary arteries to check for arterial blockages. Therefore, the rising prevalence of cardiovascular diseases across the region is a major factor driving the growth of the market. According to self-reported data from the Australian Bureau of Statistics (ABS) 2017-18 National Health Survey, an estimated 1.2 million Australian adults aged 18 years and over had one or more conditions related to the heart or vascular disease, including stroke for the year 2017-2018. Thus, owing to the rising prevalence of cardiac diseases and benefits associated with fluoroscopy, the market is expected to grow over the forecast period.

Competitive Landscape

The Asia-Pacific Fluoroscopy Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players Merck KGaA, Thermo Fisher Scientific, GE Healthcare, Sovicell GMBH, Absorption Systems , Eurofins Scientific, ADMEcell, Inc.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Carestream Health
  • Hitachi Medical Systems
  • Hologic Inc.
  • Koninklijke Philips NV
  • Orthoscan Inc.
  • Shimadzu Medical

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Geriatric Population and Prevalence of Chronic Diseases
4.2.2 Rising Demand for Minimally-invasive Surgeries
4.2.3 Increasing Use of Fluoroscopy in Pain Management
4.3 Market Restraints
4.3.1 Side Effects and Radiation Exposure
4.3.2 Rising Adoption of Refurbished Systems
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Fixed Fluoroscopes
5.1.2 Mobile Fluoroscopes
5.1.2.1 Full-size Fluoroscopes
5.1.2.2 Mini Fluoroscopes
5.2 By Application
5.2.1 Orthopedic
5.2.2 Cardiovascular
5.2.3 Pain Management and Trauma
5.2.4 Neurology
5.2.5 Gastrointestinal
5.2.6 Urology
5.2.7 General Surgery
5.2.8 Other Applications
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 Japan
5.3.1.3 India
5.3.1.4 Australia
5.3.1.5 South Korea
5.3.1.6 Rest of Asia-Pacific
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 GE Healthcare (GE Company)
6.1.3 Hitachi Medical Systems
6.1.4 Siemens Healthineers
6.1.5 Hologic Inc.
6.1.6 Orthoscan Inc.
6.1.7 Shimadzu Medical
6.1.8 Koninklijke Philips NV
6.1.9 Carestream Health
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Canon Medical Systems Corporation
  • GE Healthcare (GE Company)
  • Hitachi Medical Systems
  • Siemens Healthineers
  • Hologic Inc.
  • Orthoscan Inc.
  • Shimadzu Medical
  • Koninklijke Philips NV
  • Carestream Health
Note: Product cover images may vary from those shown

Loading
LOADING...